The emerging role of the liver in iron metabolism

American Journal of Gastroenterology

Volumn 100, Issue 1, 2005, Pages 201-206

  Sharma, Naveen ^a   Butterworth, Jeffrey ^b   Cooper, Brian T ^b   Tselepis, C ^b   Iqbal, Tariq H ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEPCIDIN; HFE PROTEIN; IRON; MEMBRANE PROTEIN; PROTEIN TFR 1; PROTEIN TFR 2; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CD71 ANTIGEN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON BINDING PROTEIN; LEUKOCYTE ANTIGEN; TRANSFERRIN RECEPTOR;

ANEMIA; HEMOCHROMATOSIS; HUMAN; IRON ABSORPTION; IRON METABOLISM; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; LIVER; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD; ANTIMICROBIAL CATIONIC PEPTIDES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON-BINDING PROTEINS; LIVER; MEMBRANE PROTEINS; RECEPTORS, TRANSFERRIN;

EID: 13744260103     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40152.x     Document Type: Review

References (52)

1. DeMaeyer EM, Dallman P, Gurney JM, et al. Preventing and controlling iron deficiency anemia through primary health care: A guide for health administrators and programme managers. Geneva, Switzerland: WHO, 1989:5-58.
2. Brittenham GM, Weiss G, Brissot P, et al. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hematology (Am Soc Hematol Educ Program) 2000;39-50.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13(4):399-408.
4. McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001;291(5509):1755-9.
5. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388(6641):482-8.
6. Fleming MD, Romano MA, Su MA, et al. Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 1998;95(3):1148-53.
7. Hubert N, Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function. Proc Natl Acad Sci USA 2002;99(19):12345-50.
8. Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000;20:627-62.
9. Monsen ER. Iron nutrition and absorption: Dietary factors which impact iron bioavailability. J Am Diet Assoc 1988;88(7):786-90.
10. Bezwoda WR, Bothwell TH, Charlton RW, et al. The relative dietary importance of haem and non-haem iron. S Afr Med J 1983;64:552-6.
11. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000;5(2):299-309.
12. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000;403(6771):776-81.
13. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a cerulo-plasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999;21(2):195-9.
14. Parkkila S, Niemela O, Britton RS, et al. Molecular aspects of iron absorption and HFE expression. Gastroenterology 2001;121(6):1489-96.
15. Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93(1):111-23.
16. Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 1998;95(5):2492-7.
17. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272(22):14025-8.
18. Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A 1997;94(23):12384-9.
19. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 1997;94(24):13198-202.
20. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95(4):1472-7.
21. Ponka P, Lok CN. The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol 1999;31(10):1111-37.
22. Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999;274(30):20826-32.
23. West AP, Jr., Bennett MJ, Sellers VM, et al. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 2000;275(49):38135-8.
24. Kawabata H, Germain RS, Ikezoe T, et al. Regulation of expression of murine transferrin receptor 2. Blood 2001;98(6):1949-54.
25. Kawabata H, Germain RS, Vuong PT, et al. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 2000;275(22):16618-25.
26. Roetto A, Totaro A, Piperno A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97(9):2555-60.
27. Fleming RE, Ahmann JR, Migas MC, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci USA 2002;99(16):10653-8.
28. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;98(15):8780-5.
29. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99(7):4596-601.
30. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110(7):1037-44.
31. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34(1):97-101.
32. Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 2002;100(10):3776-81.
33. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33(1):21-2.
34. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol 2002;282(3):G403-14.
35. Pietrangelo A. Hemochromatosis. Gut 2003;52 (Suppl 2) :ii23-30.
36. Charlton RW, Jacobs P, Bothwell TH. The role of the intestinal mucosa in iron absorption, expression in mouse liver in the face of iron overload and in hereditary. J Clin Invest 1965;44:543-54.
37. Anderson GJ, Frazer DM, Wilkins SJ, et al. Relationship between intestinal iron-transporter expression, hepatic hepcidin levels and the control of iron absorption. Biochem Soc Trans 2002;30(4):724-6.
38. Frazer DM, Anderson GJ. The orchestration of body iron intake: How and where do enterocytes receive their cues? Blood Cells Mol Dis 2003;30(3):288-97.
39. Eisenstein RS, Blemings KP. Iron regulatory proteins, iron responsive elements and iron homeostasis. J Nutr 1998;128(12):2295-8.
40. Wardrop SL, Richardson DR. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake. Eur J Biochem 1999;263(1):41-9.
41. Finch C. Regulators of iron balance in humans. Blood 1994;84(6):1697-702.
42. Andrews SC, Robinson AK, Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 2003;27:215-37.
43. Andrews NC. Anemia of inflammation: The cytokine-hepcidin link. J Clin Invest 2004;113:1251-3.
44. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101(7):2461-3.
45. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-8.
46. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
47. Lee P, Peng H, Gelbart T, et al. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 2004;101(25):9263-5.
48. Alvarez-Hernandez X, Liceaga J, McKay IC, et al. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989;61:319-22.
49. Papadaki HA, Kritikos HD, Valatas V, et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: Improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 2002;100:474-82.
50. Papadaki HA, Kritikos HD, Gemetzi C, et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: Evidence for a tumor necrosis factor alpha-mediated effect. Blood 2002;99:1610-9.
51. Ten Elshof AE, Brittenham GM, Chorney KA, et al. Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: Relevance to hemochromatosis. Immunol Rev 1999;167:223-32.
52. Meyer PN, Gerhard GS, Yoshida Y, et al. Hemochromatosis protein (HFE) and tumor necrosis factor receptor 2 (TNFR2) influence tissue iron levels: Elements of a common gut pathway? Blood Cells Mol Dis 2002;29:274-85.